Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Gachon University Collaborate on Proteomics, Glycoproteomics Biomarker Research

NEW YORK (GenomeWeb News) – Agilent Technologies today announced a collaboration with Gachon University of Medicine and Science in South Korea to use proteomics and glycoproteomics for biomarker discovery.

Under a memorandum of understanding, the laboratory at the university's College of Pharmacy will serve as Agilent's beta test site for complete glycoproteomics and biomarker discovery workflow solutions.

Agilent did not say what disease areas the research will be directed toward but said Gachon's College of Pharmacy is renowned for research into the prevention and treatment of cancer and diabetes.

Financial and other terms of the deal were not disclosed.

"Glycoproteomics is a key focal point in various aspects of life sciences research," Rod Minett, general manager of Agilent's life sciences business in South Korea and the South Asia Pacific region, said in a statement. "Through this collaboration, we hope to help scientists and researchers advance their research, unlock the genetic causes of disease and accelerate the discovery and development of new drugs."

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.